GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Biocon BIOCON.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

368.50

+0.93%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2025

Revenue

₹152.62bn

FY2016FY2025

Net income

₹10.13bn

FY2016FY2025

Free cash flow

₹17.18bn

FY2016FY2025

Shareholders' equity

₹216.44bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₹152.62bn₹147.56bn₹111.74bn₹81.84bn₹71.43bn₹63.01bn₹55.14bn₹41.30bn₹39.22bn₹33.81bn
Gross profit₹95.00bn₹92.71bn₹68.24bn₹49.78bn₹44.91bn₹43.11bn₹32.70bn₹22.18bn₹22.13bn₹18.09bn
Research and development—————₹4.10bn₹3.33bn₹2.06bn₹1.28bn₹1.32bn
Operating income₹27.77bn₹18.77bn₹15.52bn₹11.04bn₹11.17bn₹10.51bn₹9.46bn₹4.44bn₹7.05bn₹6.89bn
Net income₹10.13bn₹10.22bn₹4.63bn₹6.48bn₹7.41bn₹7.48bn₹9.05bn₹3.72bn₹6.12bn₹5.50bn
Diluted earnings per share7.548.553.855.406.176.217.633.125.164.63

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₹587.97bn₹560.71bn₹520.43bn₹203.94bn₹185.22bn₹144.44bn₹121.92bn₹99.90bn₹93.94bn₹84.58bn
Cash and short-term investments₹45.65bn₹25.74bn₹37.26bn₹29.64bn₹32.23bn₹18.55bn₹18.85bn₹19.33bn₹21.09bn₹24.13bn
Total liabilities₹371.53bn₹362.87bn₹341.76bn₹119.61bn₹108.95bn₹77.38bn₹60.94bn₹48.09bn₹45.56bn₹44.24bn
Debt₹163.99bn₹155.74bn₹179.80bn₹51.16bn₹36.70bn₹19.73bn₹18.02bn₹19.20bn₹22.05bn₹24.67bn
Shareholders' equity₹216.44bn₹197.84bn₹178.67bn₹84.33bn₹76.27bn₹67.06bn₹60.98bn₹51.81bn₹48.38bn₹40.34bn
Shares outstanding1,344m1,195m1,201m1,201m1,199m1,204m1,186m1,193m1,186m1,190m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₹40.61bn₹29.54bn₹18.52bn₹12.10bn₹11.26bn₹12.83bn₹11.55bn₹6.62bn₹6.40bn₹3.71bn
Capital spending−₹23.43bn−₹19.32bn−₹17.26bn−₹19.25bn−₹17.46bn−₹18.36bn−₹14.92bn−₹9.16bn−₹7.62bn−₹8.04bn
Free cash flow₹17.18bn₹10.22bn₹1.26bn−₹7.14bn−₹6.20bn−₹5.53bn−₹3.37bn−₹2.54bn−₹1.22bn−₹4.33bn
Dividends paid−₹829.0m−₹2.03bn−₹718.0m——−₹701.0m−₹793.0m−₹787.0m—−₹2.20bn

Latest quarters

By quarter end

Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024
Revenue₹41.73bn₹42.95bn₹39.42bn₹44.17bn₹38.21bn₹35.90bn₹34.33bn₹39.17bn
Gross profit₹28.34bn₹27.48bn₹25.37bn₹29.44bn₹24.62bn₹24.08bn₹22.50bn₹25.88bn
Operating income₹248.0m₹3.50bn₹2.94bn₹6.62bn₹3.44bn₹2.92bn₹2.15bn₹5.09bn
Net income₹1.44bn₹845.0m₹314.0m₹3.44bn₹251.0m−₹160.0m₹6.60bn₹1.35bn
Diluted earnings per share1.070.630.232.560.21-0.135.511.13
Cash from operations—₹8.03bn—₹33.56bn—₹7.05bn—₹33.31bn
Capital spending—−₹9.20bn—−₹14.42bn—−₹9.01bn—−₹10.31bn
Free cash flow—−₹1.16bn—₹19.13bn—−₹1.96bn—₹23.00bn
Total assets—₹627.60bn—₹587.97bn—₹571.28bn—₹560.71bn
Cash and short-term investments—₹64.69bn—₹45.65bn—₹31.17bn—₹25.74bn
Debt—₹111.28bn—₹163.99bn—₹125.01bn—₹155.74bn
Shareholders' equity—₹268.04bn—₹216.44bn—₹209.93bn—₹197.84bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue23.1%19.4%17.3%
Operating income36.0%21.4%19.3%
Net income16.0%6.3%7.4%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin62.5%61.9%62.7%61.2%
Operating margin15.5%14.8%15.1%15.4%
Net margin6.8%6.4%7.4%9.1%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings52.242.764.848.558.974.838.5100.852.234.1
Price to sales3.53.02.73.86.18.96.39.18.25.5

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 3 Jul 2026.

FY2026FY2025FY2024FY2023FY2020FY2019FY2018FY2016
Paid in the year0.500.501.500.500.500.500.500.833
  • 2-for-1 split · 12 Jun 2019
  • 3-for-1 split · 15 Jun 2017
  • 2-for-1 split · 11 Sept 2008

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.